Technology

Protopia AI and Lambda Announce Partnership to Provide Roundtrip Inference Data Protection to Secure LLM Endpoints

Published

1 year ago

May 6, 2025

New Roundtrip Protection Solution Delivers Full Enterprise Data Confidentiality Without Sacrificing Performance or Cost Efficiency

AUSTIN, Texas and SAN JOSE, Calif., May 6, 2025 /PRNewswire/ — Protopia AI, a pioneer in privacy-preserving AI, today announced a strategic partnership with Lambda, the AI Developer Cloud, and a leader in high-performance AI infrastructure, to deliver the first and only solution that eliminates plaintext exposure throughout the AI inference lifecycle.

Protopia AI + Lambda keep prompts/responses fully private. No plaintext exposed across the AI inference lifecycle.

Protopia’s Roundtrip Protection is the only solution that ensures sensitive data is never visible outside the client’s trusted environment, from prompt input to LLM output, enabling enterprises to retain full ownership of both their prompts and responses, even when leveraging managed inference endpoints in multi-tenant environments.

Through this partnership, enterprises can now take advantage of Lambda’s market-leading AI inference platform, optimized for performance and cost efficiency, while maintaining full data confidentiality powered by Protopia’s proprietary Stained Glass Transform.

“Enterprise AI can’t succeed in production without unlocking the most relevant internal data to flow into the most cost-efficient and scalable inference, enabling models to generate the most trusted, accurate responses. Yet many projects stall at this point, caught between the promise of managed LLM endpoints and the risk of exposing sensitive information,” said Eiman Ebrahimi, Co-founder and CEO of Protopia AI. “Our partnership with Lambda marks a new chapter where privacy, performance, and scalability go hand-in-hand, and where Lambda’s top-tier price/performance inference infrastructure is accessible with data privacy preserved across the entire roundtrip, from client to cloud to client.”

Rethinking What it Takes to Retain Ownership of Your Data with Managed Inference

LLMs fundamentally cannot run on encrypted data. This reality creates an inherent security gap during inference that grows with LLM memory capabilities and agentic workflows. Even with industry-standard encryption protocols that secure data in transit and at rest, sensitive data becomes exposed on hosting compute infrastructure in plaintext the moment it reaches an inference endpoint.

This exposure creates significant risk: a single misconfigured container or bad user password on the target compute system can leave enterprise private data exposed to unauthorized users sometimes without even triggering security alerts.

With Roundtrip Protection + Lambda Cloud, enterprises no longer have to choose between price, performance, and privacy. Enterprises can now achieve all three and accelerate their time to value with LLMs.

“We’re excited to integrate Lambda’s high-performance LLM inference platform with Protopia’s roundtrip data protection to enable enterprises in regulated industries to operationalize advanced AI models securely,” said Maxx Garrison, Director of Product Management at Lambda. “This combined solution allows organizations to scale inference workloads efficiently, preserve data confidentiality end-to-end, and accelerate deployment of state-of-the-art models with confidence.”

Request Early Access

Organizations ready to secure their inference workflows and accelerate GenAI adoption can request early access to the Protopia + Lambda Roundtrip Protection solution today by signing up here.

About Protopia AI

Protopia AI is a pioneer in privacy-preserving AI, enabling enterprises to unlock the full potential of generative AI without compromising data confidentiality. The company’s patented Stained Glass Transform technology eliminates plaintext exposure during AI inference, ensuring that sensitive data remains protected even when using third-party models or infrastructure. Trusted by organizations in regulated industries such as financial services, healthcare, public sector, and higher-ed, Protopia AI helps teams accelerate secure AI adoption while maintaining control over their most valuable assets – their data. Learn more at www.protopia.ai.

About Lambda

Lambda was founded in 2012 by AI engineers with published research at the top machine learning conferences in the world. Our GPU cloud and on-prem hardware enables AI developers to easily, securely and affordably build, test and deploy AI products at scale. Lambda’s mission is to accelerate human progress with ubiquitous and affordable access to computation. One person, one GPU.

View original content to download multimedia:https://www.prnewswire.com/news-releases/protopia-ai-and-lambda-announce-partnership-to-provide-roundtrip-inference-data-protection-to-secure-llm-endpoints-302447501.html

SOURCE Protopia AI

Technology

BlueNexus Technologies Unveils AquaX Hub at SIWW 2026 — AI Autonomous Operations Extended to Legacy Water Assets

Published

3 hours ago

June 21, 2026

SINGAPORE, June 21, 2026 /PRNewswire/ — At Singapore International Water Week (SIWW) 2026, BlueNexus Technologies unveiled the global debut of AquaX Hub™ — a compact plug-and-play edge device that brings full AI-powered autonomous operation to standalone water equipment and legacy treatment plants. The launch drew sustained engagement from utilities, industrial operators and engineering firms.

The water sector confronts converging pressures: aging infrastructure, a critical shortage of skilled technicians, and relentless operational cost escalation. AquaX Hub™ answers these directly — extending the AI autonomous operation already proven plant-wide by AquaX Robot™ to a single asset, and delivering comparable monitoring and operational management without a control-system overhaul.

“The industry cannot hire its way out of this problem,” said Jack Zhang, CEO of BlueNexus Technologies. “AI autonomous operation is no longer a future concept — the barrier to entry is gone.”

The AquaX Ecosystem

BlueNexus has built the industry’s first fully integrated AI autonomous water operation platform, spanning three complementary pillars:

AquaX Robot™ is the flagship plant-wide AI agent, built on large language models with proprietary vision, acoustic and infrared multimodal sensing. It optimizes treatment processes 24/7 and predicts equipment failures. Live deployments show up to 90% reduction in on-site staffing, a 50% drop in equipment breakdowns, and approximately 35% lower O&M costs.

AquaX Hub™, making its global debut at SIWW 2026, is a lightweight edge terminal extending that capability to any water system. With an independent local processing module, it monitors and inspects equipment through multimodal sensing and runs a self-contained processing loop. The device integrates seamlessly with existing SCADA, cloud and enterprise platforms via standardized APIs.

i-WaterHub™, the company’s standardized modular treatment plant, operated autonomously by AquaX Robot, delivers 2,500 to 40,000 m³/day for municipal and industrial applications.

Market Momentum

SIWW 2026 convened nearly 500 exhibitors from over 65 countries. BlueNexus has identified priority markets for AquaX Hub™ in Southeast Asia, the Middle East and Africa. “The conversations this week have already translated into concrete business opportunities and we expect rapid deployment in the coming months.” Zhang confirmed.

About BlueNexus Technologies

BlueNexus Technologies is a Singapore-based water-technology company building intelligent, AI-operated systems for the world’s most water-intensive industries. We design and deliver modular water treatment infrastructure that is smarter to run, faster to deploy, and built to operate autonomously.

Web: www.bluenexus.tech

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/bluenexus-technologies-unveils-aquax-hub-at-siww-2026–ai-autonomous-operations-extended-to-legacy-water-assets-302805849.html

SOURCE BlueNexus Technologies

Technology

VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS

Published

11 hours ago

June 20, 2026

With the presence of Emmanuel Macron and Narendra Modi, Prime Minister of India

PARIS, June 20, 2026 /CNW/ — From June 17 to 20, 2026 at Paris Porte de Versailles, VivaTech celebrated its 10th edition, surpassing the exceptional milestone of 200,000 visitors from 165 nationalities, with more than 15,000 startups present, 1,155 speakers and over 5 billion cumulative impressions on social media. Europe’s largest tech and innovation event has reached a new dimension, consolidating its status as an unmissable global gathering.

Exceptional speakers

VivaTech welcomed the greatest figures in global tech: Jeff Bezos (Amazon & Blue Origin), Dave Limp (Blue Origin), Bernard Arnault (LVMH), Henna Virkkunen (European Commission), Ekaterina Zaharieva (European Commission). Germany, Country of the Year 2026, was represented by a ministerial delegation, while India, AI Country Partner 2026, was led by Prime Minister Narendra Modi, as a continuation of the AI Summit in New Delhi.

Innovation and business at the heart of the event

More than 4,500 exhibitors, 61% of whom were international, showcased their latest innovations. Among the standout innovations: the smart contact lens by XPANCEO, the thought-controlled humanoid robot by Unitree x HABS, and the 3D-printed resorbable implants by Lattice Medical. New formats such as the Business Plaza and Investors Office Hours further accelerated business connections.

The VivaTech x Bloomberg Awards

For the first time, VivaTech presented the VivaTech x Bloomberg Awards, recognising the most influential figures in global tech, including Sir Tim Berners-Lee (Visionary Award), Joe Tsai (Leadership Award) and Yann LeCun (Momentum Award).

Innovation open to all

VivaTech also took over the Champs-Élysées on June 14th for an open-air technology showcase, before opening its doors to the general public on June 20th with astronaut Thomas Pesquet as guest star.

“This 10th edition was not a celebration of the 9 previous years, but the opening of a new decade full of promise.” — Maurice Lévy, Michèle Benbunan & François Bitouzet, VivaTech

See you from June 16 to 19, 2027 at Paris Expo Porte de Versailles for VivaTech 2027!

About VivaTech

VivaTech accelerates innovation by connecting startups, tech leaders, major companies, and investors responding to our world’s biggest challenges.

Each year, over four exciting days in Paris, VivaTech creates Europe’s biggest startup and tech event, exploring the most disruptive topics in tech with world-premiere demos, launches, and conferences in a collaborative ecosystem. This is where business meets innovation. Join us for the eleventh edition of VivaTech 16-19 June 2027.

For more information go to our website at https://vivatech.com/media or follow us on social media @VivaTech.

Contact
press@vivatechnology.com

Logo: https://mmx.prnewswire.com/media/MS1865564/VT_LOGO_EN.jpg
Photo : https://mmx.prnewswire.com/media/MS1869778/VivaTech_2026.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/vivatech-2026-celebrates-its-10th-anniversary-with-a-record-edition-surpassing-200-000-visitors-302805827.html

SOURCE VivaTech

Technology

Pope Leo XIV embraces paediatric patients at CNAO in Pavia

Published

14 hours ago

June 20, 2026

PAVIA, Italy, June 20, 2026 /PRNewswire/ — The National Center for Oncological Hadrontherapy (CNAO) served as the first stop today during Pope Leo XIV’s pastoral visit to the city of Pavia. His choice to begin his journey at this center reflects a profound commitment to fostering meaningful dialogue between advanced scientific progress and the alleviation of human suffering.

CNAO President Gianluca Vago and General Manager Sandro Rossi received His Holiness, illustrating the center’s distinctive capabilities. CNAO stands out as a unique reality in Italy, remaining one of the very few facilities worldwide capable of delivering hadrontherapy using both protons and carbon ions. The technological core of the facility is its synchrotron, a subatomic particle accelerator that generates ultra-high-precision beams to treat complex, inoperable and radioresistant tumours. This cutting-edge technology allows for the targeted eradication of diseased cells while meticulously preserving surrounding healthy tissues, drastically improving patients’ survival and quality of life.

Furthermore, CNAO is expanding its capabilities as a premier multi-center utilizing new ion species, like Helium, later Oxygen and Neon. Soon, treatments will incorporate the Leo Cancer Care upright positioning and imaging system. The immediate future also includes beginning therapies with a Hitachi dedicated proton accelerator and gantry and a BNCT system for metastatic diseases, equipped with an electrostatic accelerator produced by TAE Life Science. With these new technologies, CNAO will become one of the most technologically advanced center in the world.

To date, over six thousand individuals, including approximately three hundred children and adolescents, have benefited from these life-saving treatments.

During his visit, the Pope engaged with CNAO’s Board of Directors, a collaborative body uniting national universities, clinical institutions, and research centers. He also extended his heartfelt greetings to the two hundred employees of the center. These doctors, physicists, engineers, and researchers tirelessly operate the advanced technologies in the service of oncology patients.

The emotional pinnacle of the day was the Holy Father’s private gathering with a delegation of young children who underwent treatment. The paediatric patients and their families shared a deeply touching moment of closeness, receiving the Pope’s comforting embrace.

“The visit of Pope Leo XIV honours us and represents a moment of extraordinary human value”, stated CNAO President Gianluca Vago. “In his encyclical Magnifica Humanitas, the Holy Father emphasizes the necessity of a science that constantly safeguards the centrality of the person and directs technology toward the common good. In a time marked by global tensions, CNAO testifies daily how the incredible power of the atom can be used not to destroy, but to heal. The particle beams we utilize against disease are, symbolically, Rays of Hope, sharing and supporting the IAEA project bearing this name. The embrace the Holy Father reserved for our children reminds us that scientific research finds its most authentic purpose when it encounters listening, compassion, and hope”.

Photo – https://mma.prnewswire.com/media/2997869/Papa_al_Cnao_crediti_Andrea_Perotti.jpg
Logo – https://mma.prnewswire.com/media/2997643/CNAO_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/pope-leo-xiv-embraces-paediatric-patients-at-cnao-in-pavia-302805799.html